複雑な化学を知っています

Bas Gruijters is Director Process R&D and Manufacturing in Enabling Chemistry at Ardena. He brings more than 20 years of experience in small and complex molecule synthesis, along with over 15 years of managerial experience within the pharmaceutical industry. Throughout his career, Bas has worked with multidisciplinary teams to develop safe and scalable manufacturing processes supporting the advancement of numerous compounds into clinical development. His expertise spans process R&D, manufacturing, and enabling chemistry within pharmaceutical development environments. Bas obtained his PhD in Synthetic Organic Chemistry from Radboud University Nijmegen.

Jeroen Geeven is Head of QA for Ardena’s Drug Substance Solutions Division in Oss. He leads the Quality Assurance organization supporting innovative drug substance development and manufacturing programs across a broad range of pharmaceutical technologies. With more than 20 years of experience, Jeroen has developed extensive expertise in GMP quality systems, regulatory compliance, and the development and manufacture of complex APIs and nanomedicines. He is recognized for his pragmatic and solution-oriented approach, helping clients address quality and compliance challenges while supporting efficient project execution. At Ardena, he works closely with internal teams and clients to ensure quality is embedded throughout the development and manufacturing lifecycle. Jeroen is passionate about building strong partnerships and fostering a culture of quality that supports successful pharmaceutical development from early-stage programs through commercialization.

Paul van Tilborg is a senior scientific and operational leader with over 25 years of experience in analytical sciences, CMC development, and CRO operations. As Director CRO Services at Ardena in Oss, he is responsible for building and scaling bioanalytical capabilities and leading solid-state research activities, while contributing at an executive level to API analytical sciences. Paul has a strong track record in developing organisations, facilities, and teams with a clear focus on operational efficiency, customer value, and financial performance. At Ardena, he transformed the analytical sciences function from a small start-up operation into a fully established department supporting multiple development programmes, combining technical capability build-up with scalable, financially robust operations. He consistently drives growth by aligning scientific excellence with client needs, ensuring reliable delivery, transparency, and long-term partnerships. His approach emphasises fit-for-purpose solutions, efficient execution, and creating measurable value for customers and the organisation. Earlier in his career at MSD (Organon/Schering-Plough), he led analytical development teams and contributed to CMC strategies, regulatory submissions, and the delivery of complex drug development programmes. He holds a PhD in Chemistry from Utrecht University and contributes to postgraduate education through teaching in applied NMR spectroscopy.

Martin Broxterman is Principal Scientist and Group Lead at Ardena Oss. He brings extensive experience across pharmaceutical R&D and manufacturing, with a strong focus on process development, manufacturing operations, and GMP facility management. Martin joined Ardena and its predecessor organizations in 2014 as an R&D Scientist, where he developed expertise in process development and scientific problem-solving. Over the years, he has gained broad experience across both development and manufacturing environments. In his current roles as Group Lead Manufacturing and Group Lead Facility Management, he is responsible for supporting the performance, compliance, and operational readiness of Ardena’s GMP pilot plant in Oss. Martin obtained his training in Organic Chemistry and combines scientific expertise with hands-on operational leadership in pharmaceutical development and manufacturing environments.

René Steendam is Director of Solid State Research at Ardena. He combines technical expertise in solid-state chemistry with experience in project management and business development across pharmaceutical development programs. Throughout his career, René has worked across both academia and industry, contributing to global pharmaceutical development projects with a focus on crystallization and solid-form development. He has authored more than 20 scientific publications and currently serves as Chairman of the Dutch Association for Crystal Growth (DACG). René obtained his PhD in Solid-State Organic Chemistry, specializing in crystallization and solid-form development.

Peter van Hoof is Responsible Group Lead and Project Leader for Solid State Research at Ardena. He leads the scientists in the solid-state laboratory and oversees the scientific direction of customer projects supporting pharmaceutical development programs. Peter has worked in the pharmaceutical industry since 1998 as a solid-state expert, with a strong focus on the CMC development trajectory of newly developed APIs. Throughout his career, he has supported a broad range of drug development programs, building extensive expertise in solid-state characterization, crystallization, and pharmaceutical development. He has also co-authored more than 20 scientific publications in the field. Peter obtained his PhD in Solid-State Chemistry, specializing in crystallization and solid-form development.